• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

3.920 +0.230 (+6.23%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,499,693
Open 3.740
Bid (Size) 3.800 (1,000)
Ask (Size) 4.000 (1,200)
Prev. Close 3.690
Today's Range 3.730 - 4.000
52wk Range 1.665 - 6.050
Shares Outstanding 112,280,375
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Maravai LifeSciences Announces November 2025 Investor Conference Schedule
November 10, 2025
From Maravai LifeSciences, Inc.
Via Business Wire
News headline image
Maravai LifeSciences (MRVI) Stock Plummets After Q3 2025 Revenue Miss and Weak Guidance ↗
November 06, 2025
Maravai LifeSciences (MRVI) stock fell after Q3 2025 revenue missed estimates. The company reported a net loss and provided full-year guidance below analyst expectations. 
Via Chartmill

Performance

YTD
+15.3%
+15.3%
1 Month
+11.4%
+11.4%
3 Month
+11.4%
+11.4%
6 Month
+64.7%
+64.7%
1 Year
-17.8%
-17.8%

More News

Read More
News headline image
Maravai LifeSciences Reports Third Quarter 2025 Financial Results
November 06, 2025
From Maravai LifeSciences Holdings, Inc.
Via Business Wire
News headline image
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
Via Benzinga
News headline image
MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders
October 29, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
What to Expect from Maravai LifeSciences's Earnings ↗
August 08, 2025
Via Benzinga
News headline image
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025
October 22, 2025
From Maravai LifeSciences, Inc.
Via Business Wire
News headline image
MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
October 02, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 09, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Maravai LifeSciences Reports Second Quarter 2025 Financial Results
August 11, 2025
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports
August 11, 2025
Via MarketMinute
Topics Economy Stocks
News headline image
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
July 28, 2025
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Earnings Scheduled For August 11, 2025 ↗
August 11, 2025
Via Benzinga
News headline image
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
July 25, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 22, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 14, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 08, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
June 27, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer
June 25, 2025
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
June 24, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors
June 09, 2025
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology
June 03, 2025
From TriLink BioTechnologies
Via Business Wire
News headline image
CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report
May 21, 2025
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciencesReleases 2024 Sustainability Report
May 21, 2025
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions
May 20, 2025
From TriLink BioTechnologies
Via Business Wire

Frequently Asked Questions

Is Maravai LifeSciences Holdings, Inc. - Class A common stock publicly traded?
Yes, Maravai LifeSciences Holdings, Inc. - Class A common stock is publicly traded.
What exchange does Maravai LifeSciences Holdings, Inc. - Class A common stock trade on?
Maravai LifeSciences Holdings, Inc. - Class A common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Maravai LifeSciences Holdings, Inc. - Class A common stock?
The ticker symbol for Maravai LifeSciences Holdings, Inc. - Class A common stock is MRVI on the Nasdaq Stock Market
What is the current price of Maravai LifeSciences Holdings, Inc. - Class A common stock?
The current price of Maravai LifeSciences Holdings, Inc. - Class A common stock is 3.920
When was Maravai LifeSciences Holdings, Inc. - Class A common stock last traded?
The last trade of Maravai LifeSciences Holdings, Inc. - Class A common stock was at 01/16/26 04:00 PM ET
What is the market capitalization of Maravai LifeSciences Holdings, Inc. - Class A common stock?
The market capitalization of Maravai LifeSciences Holdings, Inc. - Class A common stock is 440.14M
How many shares of Maravai LifeSciences Holdings, Inc. - Class A common stock are outstanding?
Maravai LifeSciences Holdings, Inc. - Class A common stock has 440M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap